{"SPADE_N_02269": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2003/0144184 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2003_0144184_A1", "Patent Type": "Patent Application", "Publication Date": "2003-7-31", "Family Info": "EP1513544A2,EP1513544A4,EP1513544B1,US6713078,WO2004033479A2,WO2004033479A3", "Patent Title": "Retrocyclins: antiviral and antimicrobial peptides.", "Abstract": "Retrocyclin peptides are small antimicrobial agents with potent activity against bacteria and viruses. The peptides are nonhemolytic, and exhibit minimal in vitro cytotoxicity. A pharmaceutical composition comprising retrocyclin as an active agent is administered therapeutically to a patient suffering from a bacterial and/or viral infection, or to an individual facing exposure to a bacterial and/or viral infection, especially one caused by the HIV-1 retrovirus or other sexually-transmitted pathogens."}, {"Patent No": "US 2009/0264344 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2009_0264344_A1", "Patent Type": "Patent Application", "Publication Date": "2009-10-22", "Family Info": "US7314858,US7718610,US20050272645,WO2006052637A1", "Patent Title": "Retrocyclins, antiviral and antimicrobial peptides.", "Abstract": "Retrocyclin peptides are small antimicrobial agents with potent activity against bacteria and viruses. The peptides are nonhemolytic, and exhibit minimal in vitro cytotoxicity. A pharmaceutical composition comprising retrocyclin as an active agent is administered therapeutically to a patient suffering from a bacterial and/or viral infection, or to an individual facing exposure to a bacterial and/or viral infection, especially one caused by the HIV1 retrovirus or other sexuallytransmitted pathogens."}, {"Patent No": "US 2009/0264344 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2009_0264344_A1", "Patent Type": "Patent Application", "Publication Date": "2009-10-22", "Family Info": "US7314858,US7718610,US20050272645,WO2006052637A1", "Patent Title": "Retrocyclins, antiviral and antimicrobial peptides.", "Abstract": "Retrocyclin peptides are small antimicrobial agents with potent activity against bacteria and viruses. The peptides are nonhemolytic, and exhibit minimal in vitro cytotoxicity. A pharmaceutical composition comprising retrocyclin as an active agent is administered therapeutically to a patient suffering from a bacterial and/or viral infection, or to an individual facing exposure to a bacterial and/or viral infection, especially one caused by the HIV-1 retrovirus or other sexually-transmitted pathogens."}], "Sequence Information": {"SPADE ID": "SPADE_N_02269", "Peptide Name": "Rhesus theta defensin-1/2 subunit B (RTD-1b; primates, mammals, animals)", "Source": "Macaca mulatta (Rhesus macaque)", "Family": "Belongs to the alpha-defensin family (Theta subfamily)", "Gene": "RTD1B", "Sequence": "RCLCRRGVC", "Sequence Length": 9, "UniProt Entry": ["http://www.uniprot.org/uniprot/P82271"], "Protein Existence": "Protein level", "Biological Activity": ["Antimicrobial", "Antibacterial", "Antifungal"], "Target Organism": "No MICs found in DRAMP database", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "Not included yet", "Binding Target": "Not found", "Linear/Cyclic": "Not included yet", "N-terminal Modification": "Not included yet", "C-terminal Modification": "Not included yet", "Stereochemistry": "Not included yet", "Structure Description": "Not found", "Formula": "C40H76N18O10S3", "Mass": 1065.34, "PI": 9.31, "Net Charge": 3, "Hydrophobicity": 0.18, "Half Life": "Mammalian:1 hourYeast:2 minE.coli:2 min", "PTM": "contains one disulfide bond 4-9.", "Literature": [{"Title": "A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins.", "Pubmed ID": "10521339", "Reference": "Science. 1999 Oct 15;286(5439)498-502.", "Author": "Tang YQ, Yuan J, Osapay G, Osapay K, Tran D, Miller CJ, Ouellette AJ, Selsted ME.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=10521339"}, {"Title": "Circular minidefensins and posttranslational generation of molecular diversity.", "Pubmed ID": "1152799", "Reference": "J Leukoc Biol. 2001 Sep;70(3)461-464.", "Author": "Leonova L, Kokryakov VN, Aleshina G, Hong T, Nguyen T, Zhao C, Waring AJ, Lehrer RI.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=1152799"}, {"Title": "Homodimeric theta-defensins from rhesus macaque leukocytes isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides.", "Pubmed ID": "11675394", "Reference": "J Biol Chem. 2002 Feb 1;277(5)3079-3084.", "Author": "Tran D, Tran PA, Tang YQ, Yuan J, Cole T, Selsted ME.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=11675394"}], "Frequent Amino Acids": "CRG", "Absent Amino Acids": "ADEFHIKMNOPQSTUWY", "Basic Residues": 3, "Acidic Residues": 0, "Hydrophobic Residues": 2, "Polar Residues": 7, "Positive Residues": 3, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_02271", "Similarity": 1.0, "Sequence": "GFCRCLCRRGVCRCICTR"}, {"SPADE_ID": "SPADE_N_02272", "Similarity": 1.0, "Sequence": "RCLCRRGVCRCLCRRGVC"}, {"SPADE_ID": "SPADE_N_02275", "Similarity": 1.0, "Sequence": "GICRCLCRRGVCRCICVL"}]}}}